Energy Efficiency, GHG Emissions, Industrial  -  December 5, 2024

Granules’ Goals Validated by SBTi

Granules India Limited, a global pharmaceutical company, received validation and approval from the Science Based Targets initiative (SBTi) for its near-term, long-term and net-zero goals. 

The company committed to achieving net-zero GHG emissions across its value chain including all subsidiaries by FY2050. In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030, using FY2023 as the baseline, alongside transitioning to 100% renewable electricity. 

These near-term and long-term targets are aligned with the 1.5°C pathway, emphasizing Granules' dedication to climate action and achieving net zero well before FY2050. 

"Sustainability lies at the core of our decision-making and business strategy, as articulated in our purpose statement: healing lives responsibly through pioneering green science,” said Krishna Prasad Chigurupati, chairman and managing director of Granules Limited, in a statement. I am proud that Granules has received SBTi validation and approval for our near-term and long-term goals, aligned with the 1.5°C pathway toward net-zero by 2050 or sooner. This milestone strengthens our commitment to accelerate decarbonization, integrate these targets across our operations and supply chain, and drive progress through collaboration and innovation." 

Share this valuable information with your colleagues using the buttons below: